Work

c15-148: Phase I/II trial of concurrent chemohormonal therapy using enzalutamide and cabazitaxel in patients with metastatic castration resistant prostate cancer (mCRPC).

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.tps5097

Authors: Julie Nicole Graff, Tomasz M. Beer, Joshi J. Alumkal, Dustin Kreitner, Delia Petreaca, George V. Thomas, Heather H. Cheng

Institutions: Oregon Health & Science University, VA Portland Health Care System, OHSU Knight Cancer Institute, University of Washington

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2890042956

Cites:

Cited by:

Related to: 10